CompaniesHaemtech Biopharma Services

Haemtech Biopharma Services

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

0

As Collaborator

5

Total Enrollment

10,145

By Phase

PHASE2: 2PHASE4: 2

By Status

RECRUITING: 1ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
Today
NCT01567124
NCT01568307
NCT06279260
Hover over trial bars to see details

Recent Trials

NCT06279260Collaborator
National Robotics-Assisted Radical Prostatectomy Database
N/ARecruiting
10,000 participants
Started: Jul 1, 2024 · Completed: Dec 31, 2050
NCT04962126Collaborator
Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy
PHASE2Active, not recruiting
15 participants
Started: Aug 17, 2021 · Completed: Jul 31, 2025
NCT01567124Collaborator
Alleviating the Metabolic Side Effects of Antipsychotic Medications
PHASE4Withdrawn
Started: May 31, 2012
NCT01568307Collaborator
Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
PHASE4Completed
80 participants
Started: May 31, 2012 · Completed: Dec 31, 2020
NCT00784667Collaborator
Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib
PHASE2Unknown
50 participants
Started: Oct 31, 2008 · Completed: Feb 28, 2011